Correlations between MRS and DTI in cerebral small vessel disease

NMR in Biomedicine

Volumn 19, Issue 5, 2006, Pages 610-616

  Nitkunan, Arani ^a   McIntyre, Dominick J O ^a   Barrick, Thomas R ^a   O'Sullivan, Michael ^a   Shen, Yuji ^a   Clark, Chris A ^a   Howe, Franklyn A ^a   Markus, Hugh S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diffusion tensor imaging; Lacunar infarcts; Leukoaraiosis; Magnetic resonance spectroscopy; Pathology; Stroke

Indexed keywords

CHEMICAL SHIFT IMAGING; DIFFUSION TENSOR IMAGING; LACUNAR INFARCTS; LEUKOARAIOSIS; STROKE;

BLOOD VESSELS; BRAIN; MAGNETIC RESONANCE IMAGING; METABOLITES; PATHOLOGY;

BIOMEDICAL ENGINEERING;

CREATININE; N ACETYLASPARTIC ACID;

ADULT; AGED; ANISOTROPY; ARTICLE; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOARAIOSIS; MALE; METABOLITE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; WHITE MATTER;

AGED; BRAIN DISEASES; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; STATISTICS; STATISTICS AS TOPIC;

EID: 33747355683     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1052     Document Type: Article

References (31)

1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002; 1(7): 426-436.
2. Rockwood K. Vascular cognitive impairment and vascular dementia. J. Neurol. Sci. 2002; 203-204: 23-27.
3. Hachinski V, Potter P, Merskey H. Leuko-araiosis. Arch. Neurol. 1987; 44(1): 21-23.
4. Fein G, Di SV, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, Feed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui H. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000; 55(11): 1626-1635.
5. Sabri O, Ringelstein E, Hellwig D, Schneider R, Schreckenberger M, Kaiser H, et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999; 30(3): 556-566.
6. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SCR, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J. Neurol. Neurosurg. Psychiatr. 2004; 75(3): 441-447.
7. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Resonan. B 1996; 111(3): 209-219.
8. Jones D, Lythgoe D, Horsfield M, Simmons A, Williams S, Markus H. Characterization of white matter damage in ischaemic leukoaraiosis with diffusion tensor MRI. Stroke 1999; 30(2): 393-397.
9. O'Sullivan M, Summer P, Jones D, Jarosz J, Williams S, Markus H. Normal appearing white matter in ischaemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57(12): 2307-2310.
10. Pantoni L, Garcia J. The significance of cerebral white matter abnormalities 100 years after Binswanger's Report. Stroke 1995; 26(7): 1293-1301.
11. Chabriat H, Pappata S, Poupon C, Clark C, Vahedi K, Poupon F, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999; 30(12): 2637-2643.
12. Barker PB. N-acetyl aspartate - a neuronal marker? Ann. Neurol. 2001; 49(4): 423-424.
13. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 1992; 31(3): 235-241.
14. Hund-Georgiadis M, Norris D, Guthke T, von Cramon D. Characterisation of cerebral small vessel disease by proton spectroscopy and morphological magnetic resonance. Cerebrovasc. Dis. 2001; 12(2): 82-90.
15. Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosenberg GA. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997; 28(10): 1940-1943.
16. Clark CA, Barrick TR, Murphy MM, Bell BA. White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neurosurgical planning? Neuroimage 2003; 20(3): 1601-1608.
17. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001; 14(4): 260-264.
18. McLean MA, Woermann FG, Barker GJ, Duncan JS. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn. Reson. Med. 2000; 443: 401-411.
19. Pierpaoli C, Jezzard P, Basser P, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996; 201(3): 637-648.
20. Revesz T, Hawkins CP, du Boulay EP, Barnard RO, McDonald WI. Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J. Neurol. Neurosurg. Psychiatr. 1989; 52(12): 1337-1344.
21. van Swieten J, van den Hout J, van Ketel B, Hijdra A, Wokke J, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114(2): 761-774.
22. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43(9): 1683-1689.
23. Moody DM, Thore CR, Anstrom JA, Challa VR, Langefeld CD, Brown WR. Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 2004; 233(3): 883-890.
24. Barker PB, Breiter SN, Sober BJ, Chatham JC, Forder JR, Samphilipo MA, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn. Reson. Med. 1994; 32(2): 157-163.
25. Narayana P, Doyle T, Lai D, Wolinsky J. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann. Neurol. 1998; 43(1): 56-71.
26. Auer D, Schirmer T, Heidenreich J, Herzog J, Putz B, Dichgans M. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and H-MRSI study. Neurology 2001; 56(5): 635-642.
27. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anatom. Rec. 2001; 265(2): 54-84.
28. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. Am. J. Neuroradiol. 1999; 20(9): 1619-1627.
29. Steel R, Bastin M, McConnell S, Marshall I, Cunningham-Owens D, Lawrie S, et al. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatr. Res. 2001; 106(3): 161-170.
30. Eichler FS, Itoh R, Barker PB, Mori S, Garrett ES, van Zijl PC, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002; 225(l): 245-252.
31. Saunders DE, Howe FA, van den BA, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 1995; 26(6): 1007-1013.